Test-retest reproducibility of whole body [18F]FDG PET-CT in patients with malignant lung lesions.

Test-retest reproducibility of whole body [18F]FDG PET-CT in patients with malignant lung lesions. - PET-CT test-retest in patients with malignant lung lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39195

Enrollment

Registered

2012-06-06

Start date

2013-01-22

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced stage cancer metastatic cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Malignant lung lesions (of any primary) 18 years and older Expected life expectancy of

Exclusion criteria

Exclusion criteria: Pregnant or lactating Known diabetes mellitus type I and II Chemotherapy during past 4 weeks

Design outcomes

Primary

Measure	Time frame
Reproducibility of various SUV measures, metabolic and anatomic volume measurements on whole body [18F]FDG PET-CT.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results